T1	Participants 67 98	refractory rheumatoid arthritis
T2	Participants 101 186	Fifty-two patients with severe rheumatoid arthritis (RA) from four Australian centres
T3	Participants 927 1138	Seven CSA recipients (three gastrointestinal symptoms, two neurological symptoms, two other) and 12 AZA recipients (six gastrointestinal symptoms, four inefficacy, two other) withdrew from treatment prematurely.
